Article

Clinical Utility and Correlates of Cerebrospinal Fluid 14-3-3 Protein in the Evaluation of Rapid Progressive Dementia

2022-04-01

Abstract excerpt

<h4>Background: </h4> The 14-3-3 protein in cerebrospinal fluid (CSF) is a suitable marker for the differential diagnosis of patients with rapidly progressive dementia (RPD) suspected of Creutzfeldt-Jakob disease (CJD). However, the CSF 14-3-3 protein has also been detected in various non-prion-related RPD. Our objective was to investigate the general distribution of RPD with positive 14-3-3 result and to evaluate...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: db2d3b3f-8030-5f6d-9888-f81de07317fb
DOI: 10.21203/rs.3.rs-1506257/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinical Utility and Correlates of Cerebrospinal Fluid 14-3-3 Protein in the Evaluation of Rapid Progressive DementiaDOI 10.21203/rs.3.rs-1506257/v1Read

Profiles of 14-3-3 and Total Tau in CSF Samples of Chinese Patients of Different Genetic Prion DiseasesSemantic proximity Read

14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes.Semantic proximity Read

Role of Biomarkers for the Diagnosis of Prion DiseasesSemantic proximity Read

Sporadic human prion diseases: molecular insights and diagnosis.Semantic proximity Read

The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review.Semantic proximity Read

Clinical and laboratory features of 14 young Chinese probable sCJD patients.Semantic proximity Read

The advances in the early and accurate diagnosis of Creutzfeldt-Jakob disease and other prion diseases: where are we today?Semantic proximity Read

M232R Familial Creutzfeldt-Jacob Disease Challenging to Diagnose Due to the Absence of Characteristic Laboratory Findings.Semantic proximity Read

Novel PRNP mutation in a patient with a slow progressive dementia syndrome.Semantic proximity Read

[Clinical characteristics and laboratory findings in prion diseases].Semantic proximity Read

Relationships between clinicopathological features and cerebrospinal fluid biomarkers in Japanese patients with genetic prion diseases.Semantic proximity Read

Current concepts of neuropathological diagnostics in practice: neurodegenerative diseases.Semantic proximity Read